Detalhe da pesquisa
1.
Pharmacokinetics and Pharmacodynamic Effects of Nemvaleukin Alfa, a Selective Agonist of the Intermediate-Affinity IL-2 Receptor, in Cynomolgus Monkeys.
J Pharmacol Exp Ther
; 379(2): 203-210, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34362793
2.
TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function.
Nature
; 453(7192): 236-40, 2008 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-18368049
3.
Autologous human preclinical modeling of melanoma interpatient clinical responses to immunotherapeutics.
J Immunother Cancer
; 12(4)2024 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38604813
4.
Nemvaleukin alfa, a novel engineered IL-2 fusion protein, drives antitumor immunity and inhibits tumor growth in small cell lung cancer.
J Immunother Cancer
; 10(9)2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36472839
5.
ALKS 4230: a novel engineered IL-2 fusion protein with an improved cellular selectivity profile for cancer immunotherapy.
J Immunother Cancer
; 8(1)2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32317293
6.
Foxp3 is required throughout the life of a regulatory T cell.
Sci STKE
; 2007(393): pe36, 2007 Jul 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-17609478
7.
Insights into transcriptional regulation by FOXP3.
Front Biosci
; 11: 1607-19, 2006 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16368541
8.
Analysis of FOXP3 reveals multiple domains required for its function as a transcriptional repressor.
J Immunol
; 177(5): 3133-42, 2006 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16920951
9.
Characterization of flagellin expression and its role in Listeria monocytogenes infection and immunity.
Cell Microbiol
; 6(3): 235-42, 2004 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-14764107